Protein expression profiles in rat corporal smooth muscle tissue were compared between animal models of streptozotocin-induced diabetes mellitus (STZ-DM) and agematched controls (AMCs) at 1 week and 2 months after induction of hyperglycemia with STZ treatment. At each time point, protein samples from four STZ-DM and four AMC rat corpora tissues were prepared independently and analyzed together across multiple quantitative twodimensional gels using a pooled internal standard sample to quantify expression changes with statistical confidence. A total of 170 spots were differential expressed among the four experimental groups. A subsequent mass spectrometry analysis of the 170 spots identified a total of 57 unique proteins. Network analysis of these proteins using MetaCore TM suggested altered activity of transcriptional factors that are of too low abundance to be detected by the two-dimensional gel method. The proteins that were down-regulated with diabetes include isoforms of collagen that are precursors to fibril-forming collagen type 1; Hsp47, which assists and mediates the proper folding of procollagen; and several proteins whose abundance is controlled by sex hormones (e.g. CRP1 and A2U). On the other hand, proteins seen or predicted to be up-regulated include proteins involved in cell apoptosis (e.g. p53, 14-3-3-â„, Serpinf1, Cct4, Cct5, and Sepina3n), proteins that neutralize the biological activity of nerve growth factor (e.g. anti-NGF 30), and proteins involved in lipid metabolism (e.g. apoA-I and apoA-IV). Subsequent Western blot validation analysis of p53, 14-3-3-â„, and Hsp47 confirmed increased p53 and 14-3-3-â„ and decreased Hsp47 levels in separate samples. According to the results from the Western blot analysis, Hsp47 protein showed a Ïł3-fold decrease at 1 week and was virtually undetectable at 2 months in diabetic versus control. Taken together, our results identify novel candidate proteins playing a role in erectile dysfunction in diabetes resulting from STZ treatment. Molecular & Cellular Proteomics 9:565-578, 2010.
Erectile dysfunction (ED)1 is one of the many complications caused by diabetes mellitus. About 52% of men between the age of 40 and 70 years suffer from ED due to various causes, such as pathophysiological changes in nerves, blood vesicles, corporal smooth muscle tissue, and endothelial cells as well as psychological problems (such as stress) (1-3). As most of these risk factors for development of ED are inherent to diabetes mellitus, men with diabetes have a greater prevalence of ED and early onset of the disease compared with men without diabetes (4 -6). The current estimates suggest that as many as 75% of men with diabetes will develop some degree of ED at an earlier age (7). In addition, men with diabetes present with more severe dysfunction and are less responsive to current pharmacological therapies for ED (8 -10). Although ED is considered a disease impacting the "quality of life" of patients, it is often associated with depression, low self-esteem, and lower overall quality of ma...